Baihaki, Nurshiba I.
HRN: 00-28-58 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/29/2022
CEFUROXIME 500MG (TAB)
12/29/2022
01/04/2023
PO
1tab
BID
S/p NSVD W/ RMLE
Waiting Final Action